chromID™ MRSA /SAID
GUDID 03573026420758
Chromogenic medium for the screening and qualitative detection of methicillin-resistant Staphylococcus aureus and selective isolation of staphylococci and the direct identification of S. aureus.
BIOMERIEUX SA
Multiple formulation agar culture medium IVD| Primary Device ID | 03573026420758 |
| NIH Device Record Key | 06e8cd8d-c755-48ed-9b57-b1fb33121444 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | chromID™ MRSA /SAID |
| Version Model Number | chromID™ MRSA /SAID |
| Company DUNS | 276816717 |
| Company Name | BIOMERIEUX SA |
| Device Count | 10 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | true |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
Operating and Storage Conditions
| Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius |
Device Identifiers
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 03573026420758 [Package] Contains: 03573026552091 Package: [2 Units] In Commercial Distribution |
| GS1 | 03573026552091 [Primary] |
| GS1 | 03573026552107 [Unit of Use] |
FDA Pre-market Approvals/Notifications & deNovo
- Premarket Notification: K151688
FDA Product Code
| JSO | Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar |
Sterilization
| Steralize Prior To Use | false |
| Device Is Sterile | false |
Device Entry Metadata
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 5 |
| Public Version Date | 2020-02-06 |
| Device Publish Date | 2016-09-16 |
Devices Manufactured by BIOMERIEUX SA
| 03573026256685 - ETEST® Gentamicin (GM) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
| 03573026376604 - ETEST® Amoxicillin (AC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
| 03573026377731 - ETEST® Flucytosine (FC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions |
| 03573026560690 - ETEST® Meropenem/Vaborbactam (MEV) | 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an |
| 03573026475352 - ETEST® Telavancin (TLA) | 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
| 03573026252526 - ETEST® Cefepime (PM) | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
| 03573026253219 - Etest® TIC/CLAV-CON2 | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
| 03573026617851 - VITEK®MS | 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument |
Trademark Results [chromID]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CHROMID 86591765 4986430 Live/Registered |
bioMérieux 2015-04-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.